Lomitapide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Lomitapide. Educational only — not medical advice.
Labeled uses
JUXTAPID is indicated as an adjunct to a low-fat diet and exercise and other low density lipoprotein cholesterol (LDL-C) therapies to reduce LDL-C in adults and pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia (HoFH).
Source: FDA labeling via NIH DailyMed (set 61a0be9d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.